Literature DB >> 21816415

Hypertonic saline inhibits arachidonic acid priming of the human neutrophil oxidase.

Luis Lee1, Marguerite R Kelher, Ernest E Moore, Anirban Banerjee, Christopher C Silliman.   

Abstract

BACKGROUND: Arachidonic acid (AA, and its leukotriene derivatives, e.g., LTB(4)) is an inflammatory mediator in post-shock mesenteric lymph that appears to act as an agonist on G-protein coupled receptors (GPCRs). These mediators prime neutrophils (PMNs) for an increased production of superoxide, implicated in the development of acute lung injury (ALI). Hypertonic saline (HTS) has also been shown to have immunomodulatory effects such as attenuation of PMN priming by precluding appropriate clathrin-mediated endocytosis of activated GPCRs, thereby potentially attenuating ALI. We hypothesize that HTS inhibits priming of the PMN oxidase by these lipid mediators.
METHODS: After PMNs were isolated from healthy donors, incubation was done in either isotonic buffer (control) or HTS (180 mmol/L) for 5 min at 37°C. The PMNs were then primed for 10 min with AA [5 μM] or 5 min with LTB(4) [1 μM] and the oxidase was activated with 200 ng/mL of phorbol 12-myristate 13-acetate (PMA), a non-GPCR activator, and superoxide anion generation was measured via reduction of cytochrome c.
RESULTS: Both AA [5 μM] and LTB(4) [1 μM] significantly primed the PMA activated respiratory burst (P < 0.05, ANOVA, Newman-Keuls, n = 4). HTS inhibited both AA and LTB(4) priming of the respiratory burst.
CONCLUSIONS: These data indicate that HTS reduces the cytotoxicity of PMNs stimulated by these lipid mediators in vitro and further support the immunomodulatory effects of HTS.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21816415      PMCID: PMC3229642          DOI: 10.1016/j.jss.2011.06.022

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  31 in total

Review 1.  The two-event construct of postinjury multiple organ failure.

Authors:  Ernest E Moore; Frederick A Moore; Alden H Harken; Jeffrey L Johnson; David Ciesla; Ani Banerjee
Journal:  Shock       Date:  2005-12       Impact factor: 3.454

2.  The immunomodulatory effects of hypertonic saline resuscitation in patients sustaining traumatic hemorrhagic shock: a randomized, controlled, double-blinded trial.

Authors:  Sandro B Rizoli; Shawn G Rhind; Pang N Shek; Kenji Inaba; Dennis Filips; Homer Tien; Fred Brenneman; Ori Rotstein
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

3.  The N-terminal domain of Orai3 determines selectivity for activation of the store-independent ARC channel by arachidonic acid.

Authors:  Jill Thompson; Olivier Mignen; Trevor J Shuttleworth
Journal:  Channels (Austin)       Date:  2010-09-01       Impact factor: 2.581

Review 4.  Old and new generation lipid mediators in acute inflammation and resolution.

Authors:  Melanie J Stables; Derek W Gilroy
Journal:  Prog Lipid Res       Date:  2010-07-23       Impact factor: 16.195

Review 5.  Regulation of the activity of 5-lipoxygenase, a key enzyme in leukotriene biosynthesis.

Authors:  Olof Rådmark; Bengt Samuelsson
Journal:  Biochem Biophys Res Commun       Date:  2010-05-21       Impact factor: 3.575

6.  Lysophosphatidylcholines activate G2A inducing G(αi)₋₁-/G(αq/)₁₁- Ca²(+) flux, G(βγ)-Hck activation and clathrin/β-arrestin-1/GRK6 recruitment in PMNs.

Authors:  Samina Y Khan; Nathan J D McLaughlin; Marguerite R Kelher; Phillip Eckels; Fabia Gamboni-Robertson; Anirban Banerjee; Christopher C Silliman
Journal:  Biochem J       Date:  2010-11-15       Impact factor: 3.857

7.  Amantadine inhibits platelet-activating factor induced clathrin-mediated endocytosis in human neutrophils.

Authors:  Phillip C Eckels; Anirban Banerjee; Ernest E Moore; Nathan J D McLaughlin; Lynn M Gries; Marguerite R Kelher; Kelly M England; Fabia Gamboni-Robertson; Samina Y Khan; Christopher C Silliman
Journal:  Am J Physiol Cell Physiol       Date:  2009-03-18       Impact factor: 4.249

8.  Arachidonic acid in postshock mesenteric lymph induces pulmonary synthesis of leukotriene B4.

Authors:  Janeen R Jordan; Ernest E Moore; Eric L Sarin; Sagar S Damle; Sara B Kashuk; Christopher C Silliman; Anirban Banerjee
Journal:  J Appl Physiol (1985)       Date:  2008-02-14

Review 9.  5-Oxo-ETE and the OXE receptor.

Authors:  Gail E Grant; Joshua Rokach; William S Powell
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-05-18       Impact factor: 3.072

Review 10.  Postinjury multiple organ failure.

Authors:  David Dewar; Frederick A Moore; Ernest E Moore; Zsolt Balogh
Journal:  Injury       Date:  2009-06-21       Impact factor: 2.586

View more
  6 in total

Review 1.  Hypertonic Solution in Severe COVID-19 Patient: A Potential Adjuvant Therapy.

Authors:  Matheus Gennari-Felipe; Leandro Borges; Alexandre Dermargos; Eleine Weimann; Rui Curi; Tania Cristina Pithon-Curi; Elaine Hatanaka
Journal:  Front Med (Lausanne)       Date:  2022-06-21

2.  Pharmacotherapy challenges of Fontan-associated plastic bronchitis: a rare pediatric disease.

Authors:  Kristina Brooks; Regine L Caruthers; Kurt R Schumacher; Kathleen A Stringer
Journal:  Pharmacotherapy       Date:  2013-05-17       Impact factor: 4.705

3.  Andrographolide protects against LPS-induced acute lung injury by inactivation of NF-κB.

Authors:  Tao Zhu; Dao-xin Wang; Wei Zhang; Xiu-qing Liao; Xian Guan; Hong Bo; Jia-yang Sun; Ni-wen Huang; Jing He; Yun-kun Zhang; Jing Tong; Chang-yi Li
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

Review 4.  Hypertonic saline in treatment of pulmonary disease in cystic fibrosis.

Authors:  Emer P Reeves; Kevin Molloy; Kerstin Pohl; Noel G McElvaney
Journal:  ScientificWorldJournal       Date:  2012-05-03

5.  Accelerated inflammation and oxidative stress induced by LPS in acute lung injury: Ιnhibition by ST1926.

Authors:  Zewu Dong; Yufang Yuan
Journal:  Int J Mol Med       Date:  2018-03-19       Impact factor: 4.101

6.  N-acetyl-l-cystine (NAC) protects against H9N2 swine influenza virus-induced acute lung injury.

Authors:  Rui-Hua Zhang; Chun-Hong Li; Cun-Lian Wang; Ming-Ju Xu; Tong Xu; Dong Wei; Bao-Jian Liu; Guo-Hua Wang; Shu-Fei Tian
Journal:  Int Immunopharmacol       Date:  2014-06-24       Impact factor: 4.932

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.